---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-027879"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2024-07-15T23:59:59+00:00"
generated_at: "2026-05-31T20:41:56.662430+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Qualigen Therapeutics dismisses Baker Tilly, appoints Withum as new auditor

## Summary
- Dismissed Baker Tilly US, LLP effective July 11, 2024; engaged WithumSmith+Brown, PC as successor.
- Baker Tilly's reports for FY 2022 and 2023 included a going concern explanatory paragraph.
- No disagreements with Baker Tilly; a material weakness was communicated to the audit committee.
- Company authorized Baker Tilly to respond fully to Withum's inquiries regarding the material weakness.

## SEC filing metadata
- accession: 0001493152-24-027879
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2024-07-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000149315224027879/0001493152-24-027879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000149315224027879/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-027879
- JSON: https://secwatch.observer/filing/0001493152-24-027879.json
- Plain text: https://secwatch.observer/filing/0001493152-24-027879.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.